Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Apr 8:117:e220317.
doi: 10.1590/0074-02760220317. eCollection 2022.

Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis

Carmen Phang Romero  1 , Rodolfo Castro  2   3 , Pedro Emmanuel A do Brasil  4 , Daniella R Pereira  5 , Roberta Olmo Pinheiro  6 , Cristiana M Toscano  7   8 , Maria Regina Fernandes de Oliveira  8   9
Affiliations
Meta-Analysis

Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis

Carmen Phang Romero et al. Mem Inst Oswaldo Cruz. .

Abstract

Background: Leprosy is a chronic infectious disease, still endemic in many countries that may lead to neurological, ophthalmic, and motor sequelae if not treated early. Access to timely diagnosis and multidrug therapy (MDT) remains a crucial element in the World Health Organization's strategy to eliminate the disease as a public health problem.

Objectives: This systematic review aims to evaluate the accuracy of rapid point-of-care (POC) tests for diagnosis of leprosy.

Methods: Searches were carried out in electronic databases (PubMed, EMBASE, CRD, Cochrane Library and LILACS) in April 2021 for patients with suspicion or confirmatory diagnostic of leprosy, classified in multibacillary (MB) or paucibacillary (PB) cases, performing rapid POC serological tests compared to clinical evaluation, smear microscopy and immunohistochemistry analysis. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2). A meta-analysis was undertaken to generate pooled estimates of diagnostic parameters, presenting sensitivity, specificity and diagnostic odds ratio (DOR) values. The review protocol was registered at PROSPERO, CRD # 42014009658.

Findings: From 893 potentially relevant references, 12 articles were included reporting 16 diagnostic tests accuracy studies with 5395 individuals enrolled. Meta-analysis of NDO-LID and PGL-I tests data in MB patients showed sensitivity and specificity [95% confidence interval (CI)] of 0.83 (0.71-0.91), 0.91 (0.72-0.97); and 0.92 (0.86-0.96), 0.93 (0.78-0.98); respectively, with high heterogeneity among the studies.

Main conclusions: Our results can inform policymakers regarding the possibility of implementing accurate, rapid POC tests for leprosy in public health services, especially within primary health care.

PubMed Disclaimer

Figures

Fig. 1:
Fig. 1:. PRISMA 2020 - Flow chart of study selection process.
Fig. 2:
Fig. 2:. methodological quality summary: review authors’ judgements about each domain for each included study.
Fig. 3:
Fig. 3:. meta-analysis results of NDO-LID tests in multibacillary (MB) cases. Forest plot showing sensitivity and specificity of NDO-LID tests for MB cases.
Fig. 4:
Fig. 4:. meta-analysis results of PGL-I tests in in multibacillary (MB) cases. Forest plot showing sensitivity and specificity of PGL-I tests for MB cases.
See this image and copyright information in PMC

References

    1. WHO Leprosy/hansen disease: management of reactions and prevention of disabilities. Technical guidance. 2020 https://apps.who.int/iris/bitstream/handle/10665/332022/9789290227595-en...
    1. Parkash O. Classification of leprosy into multibacillary and paucibacillary groups an analysis. FEMS Immunol Med Microbiol. 2009;55(1):1–5. - PubMed
    1. Mendonça VA, Costa RD, De Melo GEBA, Antunes CM, Teixeira AL. Imunologia da hanseníase. An Bras Dermatol. 2008;83(4):343–350.
    1. Ridley DS, Jopling WH. Classification of leprosy according to immunity A five-group system. Int J Lepr Other Mycobact Dis. 1966;34(3):255–273. - PubMed
    1. WHO Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. Wkly Epidemiol Rec. 2020

Substances